Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dieter Hoelzer

Showing results (1-10 of 225) with videos related to

Pageof 23
Sort By:
Hematology. American Society of Hematology. Education Program|December 14, 2011
Novel antibody-based therapies for acute lymphoblastic leukemiaDieter Hoelzer
Clinical Advances in Hematology & Oncology : H&O|February 13, 2015
Dose-adjusted EPOCH-R for Burkitt lymphomaDieter Hoelzer
Haematologica|July 2, 2015
Personalized medicine in adult acute lymphoblastic leukemiaDieter Hoelzer
The New England Journal of Medicine|October 21, 2020
Chemotherapy-free Treatment - A New Era in Acute Lymphoblastic Leukemia?Dieter Hoelzer
Clinical Advances in Hematology & Oncology : H&O|December 5, 2006
Advances in the management of Ph-positive ALLDieter Hoelzer
Cancer|May 2, 2013
CD22 monoclonal antibody therapies in relapsed/refractory acute lymphoblastic leukemiaDieter Hoelzer
The Lancet. Oncology|February 24, 2012
Anti-CD22 therapy in acute lymphoblastic leukaemiaDieter Hoelzer
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Monitoring and managing minimal residual disease in acute lymphoblastic leukemiaDieter Hoelzer
Current Opinion in Oncology|October 8, 2013
Targeted therapy with monoclonal antibodies in acute lymphoblastic leukemiaDieter Hoelzer
Clinical Advances in Hematology & Oncology : H&O|January 16, 2010
Update on burkitt lymphoma and leukemiaDieter Hoelzer
Pageof 23

Showing results (1-10 of 225) with videos related to

Sort By:
Pageof 23
Hematology. American Society of Hematology. Education Program|December 14, 2011
Novel antibody-based therapies for acute lymphoblastic leukemiaDieter Hoelzer
Clinical Advances in Hematology & Oncology : H&O|February 13, 2015
Dose-adjusted EPOCH-R for Burkitt lymphomaDieter Hoelzer
Haematologica|July 2, 2015
Personalized medicine in adult acute lymphoblastic leukemiaDieter Hoelzer
The New England Journal of Medicine|October 21, 2020
Chemotherapy-free Treatment - A New Era in Acute Lymphoblastic Leukemia?Dieter Hoelzer
Clinical Advances in Hematology & Oncology : H&O|December 5, 2006
Advances in the management of Ph-positive ALLDieter Hoelzer
Cancer|May 2, 2013
CD22 monoclonal antibody therapies in relapsed/refractory acute lymphoblastic leukemiaDieter Hoelzer
The Lancet. Oncology|February 24, 2012
Anti-CD22 therapy in acute lymphoblastic leukaemiaDieter Hoelzer
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Monitoring and managing minimal residual disease in acute lymphoblastic leukemiaDieter Hoelzer
Current Opinion in Oncology|October 8, 2013
Targeted therapy with monoclonal antibodies in acute lymphoblastic leukemiaDieter Hoelzer
Clinical Advances in Hematology & Oncology : H&O|January 16, 2010
Update on burkitt lymphoma and leukemiaDieter Hoelzer
Pageof 23